STAT – The FDA on Friday approved a landmark rare disease treatment — the first to rely on a Nobel-prize-winning technique known as RNA interference, which silences disease-causing genes.
The Washington Post – Ancestry, 23andMe and other popular companies that offer genetic testing pledged to be upfront when they share users’ DNA data with researchers, police or other companies.
The Washington Post – Environmentalists called the decision a major blow against the 303-mile Mountain Valley Pipeline, which is being built from West Virginia though the rugged terrain of far Southwest Virginia.
InsideClimate News – FERC is considering revising how it approves natural gas pipeline projects. These states want it to focus more on costs to the environment and consumers.
Yahoo! – New Wave customers deposit a minimum of $1,000, and New Wave distributes it, based on an algorithm that assesses your risk tolerance, among 12 coins.
Reuters – The U.S. Environmental Protection Agency’s acting chief said the government will withdraw a decision to lift strict sales limits on remanufactured heavy duty vehicles known as “glider trucks”.
Gizmodo – Internal documents from IBM show that medical experts working with the company’s Watson supercomputer found “multiple examples of unsafe and incorrect treatment recommendations”.
NBC News – Home DNA test results from the 5 million customers of 23andMe will now be used by drug giant GlaxoSmithKline to design new drugs.
TSN – A lawyer for former players who have filed lawsuits against the National Hockey League said plaintiffs in the case would not appeal a judge’s July 13 decision to deny the players’ motion to proceed as a class action.
Nano and Other Emerging Chemical Technologies Blog – The final debate at the Forum used nanomaterials as a case study to argue whether product stewardship can replace regulation.
Ars Technica – The chic, plant-based Impossible Burger that browns and “bleeds” like the real thing just got a little more possible.
Nature – Gene-edited crops should be subject to the same stringent regulations as conventional genetically modified organisms (GMOs), Europe’s highest court ruled today.